R
Rani Therapeutics Holdings, Inc. (RANI)
NGM – Real vaqt narxi. Valyuta: USD
1.10
+0.03 (2.80%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
1.10
+0.03 (2.80%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Rani Therapeutics Holdings, Inc. klinik bosqichdagi bioterapevtik kompaniya bo'lib, Qo'shma Shtatlarda bemorlar, shifokorlar va sog'liqni saqlash tizimlari uchun og'riqli in'ektsiyalarga muqobil bo'lgan biologik va dori-darmonlarni og'iz orqali yuborish imkonini beruvchi texnologiyalarga qaratilgan. Kompaniya turli xil dori moddalarini, jumladan, oligonukleotidlar, peptidlar, oqsillar va antitelalarni yetkazib berish uchun dori-darmonlardan qat'iy nazar, og'iz orqali yetkazib berish platformasi bo'lgan RaniPill kapsulasini ishlab chiqadi. Uning mahsulotlar qatoriga revmatoid artritni davolash uchun preklinik tadqiqotlarda bo'lgan anti-TNF-alfa antikori RT-105; semizlikni davolash uchun kashfiyot bosqichida bo'lgan RT-116; kam uchraydigan kasalliklar uchun RT-117; va turli xil yallig'lanish holatlarini davolash uchun ustekinumab biosimilar bo'lgan RT-111 kiradi. Ular semizlikni davolash uchun RT-114 ni birgalikda ishlab chiqish va tijoratlashtirish bo'yicha ProGen Co., Ltd. bilan hamkorlik shartnomasiga ega; va gemofiliyani davolash uchun ishlab chiqilayotgan Chugai birikmasini va RaniPill HC og'iz orqali yetkazib berish moslamasini insonlarda qo'llash uchun birlashtirgan Chugai mahsulotini tijoratlashtirish bo'yicha Chugai Pharmaceutical Co., Ltd. bilan hamkorlik shartnomasiga ega. Rani Therapeutics Holdings, Inc. 2012-yilda tashkil etilgan va shtab-kvartirasi San-Xose, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Mir Hashim | Chief Scientific Officer |
| Mr. Alireza Javadi Ph.D. | Chief Technical Officer |
| Mr. Jesper Hoeiland M.Sc. | Head of Strategy |
| Mr. Mir A. Imran | Executive Chairman |
| Mr. Svai S. Sanford | Chief Financial Officer |
| Mr. Talat Imran | CEO & Director |
| Ms. Arvinder Dhalla | Vice President of Clinical Development |
| Ms. Bella Vazquez | Senior Vice President of People & Administrative Services |
| Ms. Kate McKinley M.B.A. | Chief Business Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-16 | DEFA14A | ny20067253x2_defa14a.htm |
| 2026-04-16 | DEF 14A | ny20067253x1_def14a.htm |
| 2026-03-26 | S-8 | rani-20260326.htm |
| 2026-03-26 | 10-K | rani-20251231.htm |
| 2026-01-02 | 8-K | d848686d8k.htm |
| 2025-12-05 | DEF 14C | d64642ddef14c.htm |
| 2025-12-01 | CORRESP | filename1.htm |
| 2025-11-25 | PRE 14C | d64642dpre14c.htm |
| 2025-11-10 | D | |
| 2025-11-07 | S-3 | d833820ds3.htm |